1 asset in Immune Dysregulation, Autoimmunity, And Autoinflammation

Therapeutic assets addressing Immune Dysregulation, Autoimmunity, And Autoinflammation, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Naltrexone Immune Dysregulation, Autoimmunity, And Autoinflammation	Truway Health, Inc.	P1/2	CC (47)